Breast Cancer Clinical Trials
To Participate in any of these clinical trials or for more information:
Call us at (808) 586-2979
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Study Number | Study Details |
|---|---|
ALLIANCE-A011801 Local Principal Investigator: | Official Title: The CompassHER2 Trial - (Comprehensive Use of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer) CompassHER2 Residual Disease (RD), a Double-Blinded, Phase III Randomized Trial of T-DM1 Compared With T-DM1 and Tucatinib Enrollment Status: Open: HCC, KMCWC, Pali Momi, Straub, QMC Registration to the Quality of Life (A011801-H01) Substudy is Closed to Accrual as of 07/22/2024 Cancer Type: Breast Keywords: Adjuvant Subtype: Adjuvant ClinicalTrials.gov ID: NCT04457596 Visit ClinicalTrials.gov for Complete Trial Details and Eligibility Requirements |
NRG-BR007 Local Principal Investigator: | Official Title: A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer Enrollment Status: Open: HCC, KMCWC, Straub, QMC XRT: TCCOH & QMC Cancer Type: Breast Keywords: Adjuvant Subtype: Adjuvant ClinicalTrials.gov ID: NCT04852887 Visit ClinicalTrials.gov for Complete Trial Details and Eligibility Requirements |
ALLIANCE-A012103 Local Principal Investigator: | Official Title: OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy Enrollment Status: Open: HCC, KMCWC, Straub, QMC Cancer Type: Breast Keywords: Adjuvant Subtype: Adjuvant ClinicalTrials.gov ID: NCT05812807 Visit ClinicalTrials.gov for Complete Trial Details and Eligibility Requirements |
SWOG-S2212 Local Principal Investigator: | Official Title: Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study Enrollment Status: Open: HCC, Pali Momi, Straub Pending: QMC Cancer Type: Breast Keywords: Neoadjuvant Subtype: Adjuvant ClinicalTrials.gov ID: NCT05929768 Visit ClinicalTrials.gov for Complete Trial Details and Eligibility Requirements |
SWOG-S1703 Local Principal Investigator: | Official Title: Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored With Serum Tumor Marker Directed Disease Monitoring (STMDDM) Versus Usual Care in Patients With Metastatic Hormone Receptor Positive Breast Cancer Enrollment Status: Open: HCC, KMCWC, QMC Cancer Type: Breast Keywords: Metastatic Subtype: Advanced/Metastatic 2nd line ClinicalTrials.gov ID: NCT03723928 Visit ClinicalTrials.gov for Complete Trial Details and Eligibility Requirements |
SWOG-S2010 Local Principal Investigator: | Official Title: Randomized Phase III Trial Comparing Active Symptom Monitoring Plus Patient Education Vs Patient Education Alone to Improve Persistence With Endocrine Therapy in Young Women with Stage I-III Breast Cancer (ASPEN) Enrollment Status: Open: HCC, KMCWC, Straub, Pali Momi, QMC Cancer Type: Breast Keywords: Symptom Management Subtype: Symptom Management ClinicalTrials.gov ID: NCT05568472 Visit ClinicalTrials.gov for Complete Trial Details and Eligibility Requirements |
FUKUI-2019-1 Local Principal Investigator: | Official Title: A Pilot Study: The Effect of Longitudinal Exercise Programming in Breast Cancer Patients Enrollment Status: Open: RHOP Pending: HPH, QMC Cancer Type: Breast Keywords: Exercise Subtype: Prevention (Non-interventional) ClinicalTrials.gov ID: NCT04013568 Visit ClinicalTrials.gov for Complete Trial Details and Eligibility Requirements |
NRG-CC008 Local Principal Investigator: | Official Title: A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk] Enrollment Status: Open: KMCWC Opt out: QMC Cancer Type: Breast Keywords: Surgical Procedure Subtype: Prevention (Non-interventional) ClinicalTrials.gov ID: NCT04251052 Visit ClinicalTrials.gov for Complete Trial Details and Eligibility Requirements |
ECOG-ACRIN-EA1151-TMIST Local Principal Investigator: | Official Title: Tomosynthesis Mammography Imaging Screening Trial Lead-in Enrollment Status: Open: QMC only Cancer Type: Breast Keywords: Screening Subtype: Screening (Non-interventional) ClinicalTrials.gov ID: NCT03233191 Visit ClinicalTrials.gov for Complete Trial Details and Eligibility Requirements |
